Connect with top investors and hear how pitching at RESI Boston can move your company forward.
By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN
Each RESI conference, the Innovator’s Pitch Challenge (IPC) allows life science entrepreneurs to present their technologies to a panel of active investors and strategic partners. Companies pitch live to an audience of relevant investors, receive direct feedback, and make meaningful connections critical to their next stage of growth.
The Innovator’s Pitch Challenge (IPC) continues to demonstrate its impact as a key catalyst for fundraising and visibility. Success stories continue to emerge: at RESI JPM 2024, Convergence Medical, who won second place at the IPC and subsequently closed a $5 million Series A funding round led by Avicella Capital, a member of LSN’s Global Partnering Network.
Meet Some of Our Past Investor Judges
The Innovator’s Pitch Challenge is defined by the quality of its judging panel. Each session features active investors and strategic partners who bring deep expertise in early-stage life investment. Past IPC judges have included representatives from:
 Brent Ahrens Canaan Partners |
 Jeroen Blokhuis General Inception |
 Christopher Church AstraZeneca |
 Tom Gibbs Debiopharm Innovation Fund |
 Christopher Haskell, Ph.D. Johnson & Johnson Innovation |
 Claire Leurent AbbVie Ventures |
 Fiona Mack Bayer |
 Jeffrey Moore MP Healthcare Venture Management |
 Stephanie Rusinkiewicz Medtronic |
 Joachim Scholpp Boehringer Ingelheim |
 Christopher Tan Merck |
 Tad Weems Agilent Technologies |
These seasoned judges provide live, interactive feedback, offering startups not just visibility but a chance to start lasting conversations with global early-stage investors.
Hear From Past IPC Winners
Past IPC participants have shared how the experience helped move their ventures forward:
Diana Caldwell, CEO and Co-Founder of Amplified Sciences, shared,
“Participating in the IPC was a pivotal moment for our company. The opportunity to present our technology to a room full of engaged investors and receive immediate feedback was invaluable. It not only validated our approach but also opened doors to partnerships we had not anticipated.”
John Qiao, Founder and CEO of RadioClash, said,
“RESI’s Innovator’s Pitch Challenge provided a rare chance to engage directly with investors in a dynamic setting. The interactive feedback helped sharpen our fundraising strategy, and the conference environment led to meaningful follow-up meetings.”
Michael Yu, Founder and CEO of EYWA Biotech, noted,
“The IPC experience was energizing and highly beneficial. It forced us to hone our pitch to its essentials, and the conversations we had during and after the event helped expand our investor network in ways that continue to pay off.”
Beyond the pitch session, IPC participants receive a dedicated exhibit space in the RESI Exhibition Hall, full access to one-on-one partnering, and the chance to win complimentary registration to a future RESI conference.
If you are an early-stage entrepreneur working in therapeutics, diagnostics, medical devices, or digital health, the Innovator’s Pitch Challenge at RESI Boston is your opportunity to stand out.
Apply today to pitch at RESI Boston, taking place June 16, 2025, and move your fundraising forward. Space in the Innovator’s Pitch Challenge is limited, and competition for spots is high. Now is the time to apply and secure your chance to be part of RESI Boston this June.
Next Phase Newsletter 
Leave a comment